Leveraging findings from comparative studies, like those examining GATA-3 expression in canine mammary tumors—where it has shown correlations with favorable prognostic factors—can provide additional layers of understanding regarding the potential implications of AR expression in human breast cancer [57]. The gene discussed is GATA3; the disease is breast cancer.